IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in IDEAYA Biosciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- −7 vs. Q4 2021
- Shares held
- 35.1M
- +345.3K (+1.0%) vs. Q4 2021
- Total value
- $392.9M
- −$427.8M (−52.1%) vs. Q4 2021
- New holders
- 12
- 43 more added
- Sold out
- 19
- 31 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IDYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 285 | $3.80B |
| Q1 2026 | 254 | $3.16B |
| Q4 2025 | 246 | $3.32B |
| Q3 2025 | 224 | $2.56B |
| Q2 2025 | 204 | $2.04B |
| Q1 2025 | 207 | $1.54B |
| Q4 2024 | 206 | $2.36B |
| Q3 2024 | 209 | $2.91B |
| Q2 2024 | 199 | $2.90B |
| Q1 2024 | 204 | $3.47B |
| Q4 2023 | 157 | $2.35B |
| Q3 2023 | 144 | $1.61B |
| Q2 2023 | 138 | $1.33B |
| Q1 2023 | 128 | $625.4M |
| Q4 2022 | 117 | $835.0M |
| Q3 2022 | 112 | $667.1M |
| Q2 2022 | 96 | $489.0M |
| Q1 2022 | 103 | $392.9M |
| Q4 2021 | 110 | $820.7M |
| Q3 2021 | 91 | $837.9M |
| Q2 2021 | 84 | $533.4M |
| Q1 2021 | 89 | $558.6M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding IDEAYA Biosciences, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Canaan Partners X LLC | 2,660,713 | $29.8M | 30.23% | 00.0% | Unchanged |
| Avidity Partners Management LP | 2,690,000 | $30.1M | 0.67% | +137,000+5.4% | Added |
| Logos Global Management LP | 2,850,000 | $31.9M | 4.13% | +1,300,000+83.9% | Added |
| RTW Investments, LP | 0 | $0 | 0.00% | −2,520,076−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −498,187−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −430,000−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −235,695−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −20,454−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,361−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −15,234−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −12,336−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −11,146−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −10,100−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −9,915−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −8,793−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −3,100−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −2,484−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −1,646−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −187−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |